Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment (MAFRI)

This study has been completed.
Information provided by (Responsible Party):
Pere Gines, Hospital Clinic of Barcelona Identifier:
First received: May 19, 2010
Last updated: August 17, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)